Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(GLENMARK) Glenmark Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Glenmark Pharmaceuticals | (GLENMARK) share price targets

Complete technical analysis of Glenmark Pharmaceuticals (GLENMARK) by charts plus indicators, forecast predictions and share price targets for Glenmark Pharmaceuticals (GLENMARK)

Glenmark Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2025-07-21 View latest technical analysis

10 day averaged volume of Glenmark Pharmaceuticals is 3418350

Date	Daily Closing Price	Open	High	Low	Volume
21 Mon Jul 2025	2184.80	2227.90	2237.80	2176.70	0.483 times
18 Fri Jul 2025	2225.50	2224.90	2254.90	2194.50	0.372 times
17 Thu Jul 2025	2226.70	2221.00	2266.00	2179.00	0.962 times
16 Wed Jul 2025	2204.80	2220.00	2247.70	2196.10	0.437 times
15 Tue Jul 2025	2226.10	2205.10	2233.90	2170.40	0.487 times
14 Mon Jul 2025	2219.20	2170.10	2229.00	2138.50	1.046 times
11 Fri Jul 2025	2181.10	2094.40	2284.80	2094.40	4.587 times
10 Thu Jul 2025	1904.00	1821.90	1920.00	1813.10	1.001 times
09 Wed Jul 2025	1818.80	1826.00	1832.90	1792.60	0.355 times
08 Tue Jul 2025	1830.50	1860.10	1862.00	1822.10	0.431 times

My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 2141.8, but if it comes below 2141.8, then a intra day sell could be more profitable.
If you take a sell trade below 2141.8, then use 2141.8 as stoploss and 1930.85 as target. However if you take a buy trade in stock , then use 2141.8 as stoploss and 2395 as target.

Share price targets for Glenmark Pharmaceuticals (GLENMARK)

Target Type	Value
Downside Target	1277.30
Downside Target	1336.00
Downside Target	1448.50
Downside Target	1546.40
Downside Target	1582.95
Downside Target	1630.10
Downside Target	1715.40
Downside Target	1843.30
Downside Target	2138.50
Downside Target	2176.70
Upside Target	2237.80
Upside Target	2266.00
Upside Target	2284.80

Intraday share price targets for Glenmark Pharmaceuticals (GLENMARK)

Target Type	Value
Downside Intraday Target	2161.73
Downside Intraday Target	2138.67
Upside Intraday Target	2222.83
Upside Intraday Target	2260.87
Upside Intraday Target	2199.77

Weekly technical analysis of Glenmark Pharmaceuticals (GLENMARK)

Date	Weekly Closing Price	Open	High	Low	Volume
21 Mon Jul 2025	2184.80	2227.90	2237.80	2176.70	0.146 times
18 Fri Jul 2025	2225.50	2170.10	2266.00	2138.50	0.494 times
11 Fri Jul 2025	2181.10	1836.10	2284.80	1792.60	7.299 times
04 Fri Jul 2025	1830.40	1719.90	1843.30	1715.40	0.477 times
27 Fri Jun 2025	1711.20	1636.00	1743.60	1630.10	1.27 times

Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Glenmark Pharmaceuticals (GLENMARK)

Date	Monthly Closing Price	Open	High	Low	Volume
21 Mon Jul 2025	2184.80	1752.20	2284.80	1740.10	1.496 times
30 Mon Jun 2025	1753.80	1457.20	1758.20	1448.50	1.622 times
30 Fri May 2025	1457.10	1381.20	1471.10	1355.40	1.025 times
30 Wed Apr 2025	1381.20	1540.00	1582.95	1336.00	1.342 times

Scroll below to view daily charts

Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Glenmark Pharmaceuticals (GLENMARK)

Price action analysis of Glenmark Pharmaceuticals ( (GLENMARK) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

Price action analysis of Glenmark Pharmaceuticals ( (GLENMARK) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Price action analysis of Glenmark Pharmaceuticals ( (GLENMARK) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Price action analysis of Glenmark Pharmaceuticals ( (GLENMARK) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Glenmark Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.

MACD generated a BUY signal for Glenmark Pharmaceuticals in short term and the buy signal is strong.

Glenmark Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Glenmark Pharmaceuticals in short term but SELL signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Glenmark Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2139.5 and Glenmark Pharmaceuticals (GLENMARK) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Glenmark Pharmaceuticals (GLENMARK) stock. Volume based technical analysis of Glenmark Pharmaceuticals (GLENMARK) stock is negative.

Glenmark Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.